Report Detail
Global (United States, European Union and China) Glaucoma Pharmaceuticals Market Research Report 2019-2025
- RnM3651005 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqueous humor. Depending on the size of trabecular meshwork blockage, glaucoma can be categorized as open angle and narrow closure glaucoma. In open angle glaucoma trabecular meshwork blockage is wider than narrow angle glaucoma. This disease results in various symptoms such as redness in eye, nausea, vomiting, narrowing in vision and pain. This disease can be diagnosed by measuring eye pressure through tonometry.
Key growth drivers of the market include rising ageing population, healthcare expenditures, medical coverage and new innovative combination drugs. The market players in medication as well as devices segments are totally different and somewhat very fragmented.
In 2019, the market size of Glaucoma Pharmaceuticals is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Glaucoma Pharmaceuticals.
This report studies the global market size of Glaucoma Pharmaceuticals, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Glaucoma Pharmaceuticals sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Acadia Pharmaceuticals Inc.
Allergan Inc.
Inotek Pharmaceuticals Corporation
Merck & Co. Inc.
Santen Pharmaceutical Co.Ltd.
Novartis International AG
...
Market Segment by Product Type
Prostaglandins Analogues (PGAs)
Non PGAs
Market Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Glaucoma Pharmaceuticals status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Glaucoma Pharmaceuticals manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Glaucoma Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Glaucoma Pharmaceuticals Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Prostaglandins Analogues (PGAs)
- 1.3.3 Non PGAs
- 1.4 Market Segment by Application
- 1.4.1 Global Glaucoma Pharmaceuticals Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Private Clinics
- 1.4.4 Drug Stores
- 1.4.5 Retail Pharmacies
- 1.4.6 E-Commerce
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Glaucoma Pharmaceuticals Market Size
- 2.1.1 Global Glaucoma Pharmaceuticals Revenue 2014-2025
- 2.1.2 Global Glaucoma Pharmaceuticals Sales 2014-2025
- 2.2 Glaucoma Pharmaceuticals Growth Rate by Regions
- 2.2.1 Global Glaucoma Pharmaceuticals Sales by Regions 2014-2019
- 2.2.2 Global Glaucoma Pharmaceuticals Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Glaucoma Pharmaceuticals Sales by Manufacturers
- 3.1.1 Glaucoma Pharmaceuticals Sales by Manufacturers 2014-2019
- 3.1.2 Glaucoma Pharmaceuticals Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Glaucoma Pharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 Glaucoma Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Glaucoma Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
- 3.3 Glaucoma Pharmaceuticals Price by Manufacturers
- 3.4 Key Manufacturers Glaucoma Pharmaceuticals Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Glaucoma Pharmaceuticals Market
- 3.6 Key Manufacturers Glaucoma Pharmaceuticals Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Prostaglandins Analogues (PGAs) Sales and Revenue (2014-2019)
- 4.1.2 Non PGAs Sales and Revenue (2014-2019)
- 4.2 Global Glaucoma Pharmaceuticals Sales Market Share by Type
- 4.3 Global Glaucoma Pharmaceuticals Revenue Market Share by Type
- 4.4 Glaucoma Pharmaceuticals Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Glaucoma Pharmaceuticals Sales by Application
6 United States
- 6.1 United States Glaucoma Pharmaceuticals Breakdown Data by Company
- 6.2 United States Glaucoma Pharmaceuticals Breakdown Data by Type
- 6.3 United States Glaucoma Pharmaceuticals Breakdown Data by Application
7 European Union
- 7.1 European Union Glaucoma Pharmaceuticals Breakdown Data by Company
- 7.2 European Union Glaucoma Pharmaceuticals Breakdown Data by Type
- 7.3 European Union Glaucoma Pharmaceuticals Breakdown Data by Application
8 China
- 8.1 China Glaucoma Pharmaceuticals Breakdown Data by Company
- 8.2 China Glaucoma Pharmaceuticals Breakdown Data by Type
- 8.3 China Glaucoma Pharmaceuticals Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Glaucoma Pharmaceuticals Breakdown Data by Company
- 9.2 Rest of World Glaucoma Pharmaceuticals Breakdown Data by Type
- 9.3 Rest of World Glaucoma Pharmaceuticals Breakdown Data by Application
- 9.4 Rest of World Glaucoma Pharmaceuticals Breakdown Data by Countries
- 9.4.1 Rest of World Glaucoma Pharmaceuticals Sales by Countries
- 9.4.2 Rest of World Glaucoma Pharmaceuticals Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Acadia Pharmaceuticals Inc.
- 10.1.1 Acadia Pharmaceuticals Inc. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Glaucoma Pharmaceuticals
- 10.1.4 Glaucoma Pharmaceuticals Product Introduction
- 10.1.5 Acadia Pharmaceuticals Inc. Recent Development
- 10.2 Allergan Inc.
- 10.2.1 Allergan Inc. Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Glaucoma Pharmaceuticals
- 10.2.4 Glaucoma Pharmaceuticals Product Introduction
- 10.2.5 Allergan Inc. Recent Development
- 10.3 Inotek Pharmaceuticals Corporation
- 10.3.1 Inotek Pharmaceuticals Corporation Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Glaucoma Pharmaceuticals
- 10.3.4 Glaucoma Pharmaceuticals Product Introduction
- 10.3.5 Inotek Pharmaceuticals Corporation Recent Development
- 10.4 Merck & Co. Inc.
- 10.4.1 Merck & Co. Inc. Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Glaucoma Pharmaceuticals
- 10.4.4 Glaucoma Pharmaceuticals Product Introduction
- 10.4.5 Merck & Co. Inc. Recent Development
- 10.5 Santen Pharmaceutical Co.Ltd.
- 10.5.1 Santen Pharmaceutical Co.Ltd. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Glaucoma Pharmaceuticals
- 10.5.4 Glaucoma Pharmaceuticals Product Introduction
- 10.5.5 Santen Pharmaceutical Co.Ltd. Recent Development
- 10.6 Novartis International AG
- 10.6.1 Novartis International AG Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Glaucoma Pharmaceuticals
- 10.6.4 Glaucoma Pharmaceuticals Product Introduction
- 10.6.5 Novartis International AG Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Glaucoma Pharmaceuticals Sales Channels
- 11.2.2 Glaucoma Pharmaceuticals Distributors
- 11.3 Glaucoma Pharmaceuticals Customers
12 Market Forecast
- 12.1 Global Glaucoma Pharmaceuticals Sales and Revenue Forecast 2019-2025
- 12.2 Global Glaucoma Pharmaceuticals Sales Forecast by Type
- 12.3 Global Glaucoma Pharmaceuticals Sales Forecast by Application
- 12.4 Glaucoma Pharmaceuticals Forecast by Regions
- 12.4.1 Global Glaucoma Pharmaceuticals Sales Forecast by Regions 2019-2025
- 12.4.2 Global Glaucoma Pharmaceuticals Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Glaucoma Pharmaceuticals. Industry analysis & Market Report on Glaucoma Pharmaceuticals is a syndicated market report, published as Global (United States, European Union and China) Glaucoma Pharmaceuticals Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Glaucoma Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
